North America Infusion Pumps Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The North America Infusion Pumps Market size is expected to reach US$ 7,826.3 Million by 2034 from US$ 4,688.6 Million in 2025. The market is estimated to record a CAGR of 5.9% from 2026 to 2034.

Executive Summary and North America Infusion Pumps Market Analysis:

The North America Infusion Pump market is segmented into the US, Canada, and Mexico. The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders has driven demand for precise and continuous drug delivery systems. The region's aging population further contributes to this trend, as older adults often require long-term medication management and home healthcare solutions. Technological advancements in infusion pumps-including smart pumps with integrated safety features, wireless connectivity, and real-time monitoring-have enhanced patient safety and treatment efficacy, making them more appealing to healthcare providers.

Additionally, the rising adoption of home healthcare services and outpatient care is fueling demand for portable and easy-to-use infusion devices. Favorable healthcare infrastructure, strong reimbursement policies, and the presence of leading medical device manufacturers in North America further support market expansion. Awareness about medication errors and the need for accurate drug administration has also encouraged hospitals and clinics to invest in advanced infusion systems. Moreover, the COVID-19 pandemic highlighted the importance of efficient and remote drug delivery, accelerating the adoption of infusion technology. Collectively, these factors create a robust environment for the sustained market growth in North America.

North America Infusion Pumps Market: Strategic Insights

North America Infusion Pumps Market Segmentation Analysis:

• By Product, the North America Infusion Pumps Market is segmented into IV infusion Pumps, Syringe Infusion Pumps, Volumetric infusion Pumps, Ambulatory Pumps, Patient-Controlled Analgesia (PCA) Pumps, Enteric Feeding Pumps, Disposable Elastomeric Pumps, and Others. The IV infusion Pumps segment dominated the market in 2025.
• By Customer, the North America Infusion Pumps Market is segmented into Small Hospitals and Nursing Home, Standalone Hospitals, Tertiary Care Hospitals, and Hospital Chain. The Tertiary Care Hospitals segment dominated the market in 2025.
• By End User, the North America Infusion Pumps Market is segmented into Anaesthesiologists, Critical Care Specialists, and Others. The Anaesthesiologists segment dominated the market in 2025.

North America Infusion Pumps Market Players Density: Understanding Its Impact on Business Dynamics

The North America Infusion Pumps Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Infusion Pumps Market Outlook

According to the World Health Organization (WHO), noncommunicable diseases (NCDs)-including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes-claimed 43 million lives in 2021, representing 75% of non-pandemic-related deaths worldwide, with 82% of premature fatalities in low- and middle-income countries.

Cardiovascular disease is the leading cause of death globally. According to the WHO, in 2022, cardiovascular disease claimed 19.8 million lives worldwide, representing 32% of all deaths, with a prevalence reaching 612 million cases. Projections indicate a 90% increase in cardiovascular disease prevalence between 2025 and 2050. Additionally, according to the IDF Diabetes Atlas, approximately 589 million adults worldwide lived with diabetes in 2024, with 252 million undiagnosed, and numbers expected to hit 853 million by 2050. This surge is linked to factors such as urbanization and lifestyle changes, amplifying the need for reliable infusion systems.

In diabetes management, insulin infusion pumps like those approved by the US Food and Drug Administration (FDA) provide continuous subcutaneous insulin infusion, helping maintain stable blood glucose levels and reducing complications such as neuropathy or retinopathy. National Institutes of Health (NIH) study on infusion pumps highlights how these pumps improve glycemic control in patients with Type 1 diabetes, where traditional injections often fall short. Similarly, for cancer patients, chemotherapy infusion pumps deliver targeted doses of drugs like doxorubicin or cisplatin, minimizing side effects while ensuring therapeutic efficacy.

Globally, approximately one in three adults suffers from multiple chronic conditions, and according to recent data by the National Center for Chronic Disease Prevention and Health Promotion, approximately 76.4% of US adults-representing 194 million people-reported at least one chronic condition in 2023, up from 72.3% a decade earlier. According to the Institute for Health Metrics and Evaluation data, risks such as high blood pressure and obesity are worsening this condition, with chronic diseases projected to cause 86% of deaths by 2050 globally if unchecked. These statistics emphasize that noncommunicable diseases (NCDs) disproportionately impact vulnerable populations, and that infusion pumps reduce medication errors through features such as dose error reduction systems (DERS), as promoted by the FDA's Infusion Pump Improvement Initiative. Additionally, in low-income regions, where 82% of premature NCD deaths occur, portable infusion devices offer accessible treatment options, bridging gaps in healthcare infrastructure.

Overall, the integration of infusion pumps in chronic care protocols enhances patient outcomes, reduces hospital readmissions, and supports home-based therapies.

North America Infusion Pumps Market Country Insights

By country, the North America Infusion Pumps Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2025.

In the US, the rapid rise in the aging population, coupled with prolonged periods of physical inactivity, has contributed to a higher incidence of lifestyle-related disorders, including cardiovascular diseases (CVDs), diabetes, and obesity. As reported by the Centers for Disease Control and Prevention (CDC) in 2023, diabetes affects approximately 40.1 million adults, representing 12% of the population, with 29.1 million diagnosed cases. Undiagnosed diabetes accounts for nearly 11 million individuals, exacerbating the demand for advanced insulin pumps.

Additionally, approximately 1.4 million new diabetes cases are reported annually in the country. Yale researchers also reported that in 2022, roughly 30 million individuals in the US had diabetes, with nearly 7 million requiring daily insulin therapy. Insulin pumps play a crucial role in diabetes management. These devices consist of a reservoir connected to a small plastic tube called a cannula, through which insulin is delivered into fatty tissue.

The US infusion pump market is further supported by the increasing number of product approvals by the US Food and Drug Administration (FDA) and the strong presence of key market players. Notable examples include:

October 2025: SQ Innovation received FDA approval for Lasix ONYU, a subcutaneous infusion system for heart failure edema, expanding ambulatory options.

May 2025: Iradimed's MRidium 3870 MRI-compatible infusion pump received the FDA's 510(k) clearance, enhancing safety during MRI procedures.

May 2024: Moog Inc. received 510(k) clearance for the CURLIN 8000 Ambulatory Infusion System, a premium platform designed for home infusion applications.

August 2023: ICU Medical, Inc. announced FDA 510(k) clearance for the Plum Duo infusion pump, equipped with LifeShield infusion safety software.

July 2023: BD received 510(k) clearance for the updated BD Alaris Infusion System, enabling remediation and a full return to commercial operations for one of the most comprehensive infusion systems in the US.

Overall, the rising prevalence of diabetes, combined with the increasing number of FDA-approved products, is driving demand for infusion pumps in the US.

North America Infusion Pumps Market Company Profiles

Some of the key players operating in the market include Terumo Corp, Baxter International Inc, ICU Medical Inc, Fresenius Kabi AG, B. Braun Melsungen AG, Becton Dickinson and Co, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Shenzhen Comen Medical Instruments Co., Ltd., Allied Medical Limited, and Beijing KellyMed Co., Ltd.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Infusion Pumps Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise